These effects, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the strategy of focusing on ACKR3 as a novel strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked Ailments. Importantly, these receptors were https://howardx703dzv2.aboutyoublog.com/profile